AngioDynamics Inc (FRA:UG2)
€ 6.15 -0.1 (-1.67%) Market Cap: 261.21 Mil Enterprise Value: 205.71 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 66/100

AngioDynamics Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 05:00PM GMT
Release Date Price: €17 (+1.19%)
Stephanie Laura Piazzola
BofA Securities, Research Division - Associate

Joining us today for the AngioDynamics presentation. My name is Stephanie Piazzola, and I cover medical devices at Bank of America. Before we get started, I just wanted to introduce with us today is Jim Clemmer, President and CEO of AngioDynamics. And with that, I'll hand it over to Jim for the presentation.

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

Thanks, Stephanie. Thanks, Stephanie. Thanks to Bank of America for the conference today. Looking forward to taking a few minutes to share with you about AngioDynamics, our story of transformation and why we think we can add significant value to our stakeholders over the next number of years.

So first, remember that everything I say here today are our plans and ideas of knowledge of the market and the things we'll do to affect increasing the value of our company. But there's no guarantee of everything I say will work. So you use your knowledge, understand the forward-looking statements to the best research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot